Literature DB >> 22350902

Affinity purification of mammalian 26S proteasomes using an ubiquitin-like domain.

Henrike C Besche1, Alfred L Goldberg.   

Abstract

The standard methods for the isolation of the 26S proteasomes from mammalian tissues have long involved multiple chromatographic steps. This process led to loss of loosely associated regulatory proteins or cofactors and yielded particles with low functional capacity. Here, we describe a single-step affinity purification of 26S proteasome complexes that preserves the association with many 26S proteasome-interacting proteins. Our approach uses the ubiquitin-like domain of human RAD23B as an affinity bait, which allows the rapid and gentle isolation of 26S proteasomes with high purity. This strategy does not require the genetic introduction of tagged subunits nor expensive antibodies, and therefore can be used to isolate 26S proteasomes from any mammalian tissue or yeast. This method, therefore, is an important new tool to study 26S proteasome function in various models of human diseases that are linked to changes in the ubiquitin proteasome system, for example the increased proteasomal proteolysis seen in muscle wasting or the decreased proteasomal capacity that has been reported in various neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22350902     DOI: 10.1007/978-1-61779-474-2_29

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  17 in total

1.  Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.

Authors:  Natura Myeku; Catherine L Clelland; Sheina Emrani; Nikolay V Kukushkin; Wai Haung Yu; Alfred L Goldberg; Karen E Duff
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

2.  The deubiquitinating enzyme Usp14 allosterically inhibits multiple proteasomal activities and ubiquitin-independent proteolysis.

Authors:  Hyoung Tae Kim; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2017-04-17       Impact factor: 5.157

3.  26S proteasomes become stably activated upon heat shock when ubiquitination and protein degradation increase.

Authors:  Donghoon Lee; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2022-06-15       Impact factor: 12.779

4.  UBL domain of Usp14 and other proteins stimulates proteasome activities and protein degradation in cells.

Authors:  Hyoung Tae Kim; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-11-28       Impact factor: 11.205

5.  ZFAND5/ZNF216 is an activator of the 26S proteasome that stimulates overall protein degradation.

Authors:  Donghoon Lee; Shinichi Takayama; Alfred L Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-25       Impact factor: 11.205

6.  cAMP-induced phosphorylation of 26S proteasomes on Rpn6/PSMD11 enhances their activity and the degradation of misfolded proteins.

Authors:  Sudarsanareddy Lokireddy; Nikolay Vadimovich Kukushkin; Alfred Lewis Goldberg
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-15       Impact factor: 11.205

7.  Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation.

Authors:  Galen Andrew Collins; Zhe Sha; Chueh-Ling Kuo; Beyza Erbil; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2022-03-28       Impact factor: 5.486

8.  Phosphatase UBLCP1 controls proteasome assembly.

Authors:  Shuangwu Sun; Sisi Liu; Zhengmao Zhang; Wang Zeng; Chuang Sun; Tao Tao; Xia Lin; Xin-Hua Feng
Journal:  Open Biol       Date:  2017-05       Impact factor: 6.411

Review 9.  Mechanisms That Activate 26S Proteasomes and Enhance Protein Degradation.

Authors:  Alfred L Goldberg; Hyoung Tae Kim; Donghoon Lee; Galen Andrew Collins
Journal:  Biomolecules       Date:  2021-05-22

10.  A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.

Authors:  Tiffany A Thibaudeau; Raymond T Anderson; David M Smith
Journal:  Nat Commun       Date:  2018-03-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.